# CIPRO HC

NDC: 76420-273
Generic name: ciprofloxacin hydrochloride and hydrocortisone
Labeler / Manufacturer: Asclemed USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION/ DROPS
Routes: AURICULAR (OTIC)
Marketing started: 19990315

FDA application: NDA020805

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 2 mg/mL
- HYDROCORTISONE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76420-273"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-273
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eafad445-2735-434b-a1c6-e1c6b201d2cf